Comments on: Monday Biotech Deal Review: October 12, 2009 http://crossborderbiotech.ca/2009/10/12/monday-biotech-deal-review-october-12-2009/ Biotechnology, Health and Business in Canada, the United States and Worldwide Mon, 02 Apr 2012 12:31:04 +0000 hourly 1 http://wordpress.com/ By: Monday Biotech Deal Review: November 16, 2009 « The Cross-Border Biotech Blog http://crossborderbiotech.ca/2009/10/12/monday-biotech-deal-review-october-12-2009/comment-page-1/#comment-1086 Tue, 17 Nov 2009 02:10:24 +0000 http://crossborderbiotech.ca/?p=3352#comment-1086 [...] Inc. (TSXV: MIR) (NASDAQ:MMIRF) and Swiss investment company Andurja AG announced the completion of Andurja’s $2M equity investment in MedMira. Andurja now owns 19.85% of MedMira’s common shares and will take a seat on MedMira’s [...]

]]>